Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status
Authors
Keywords
miRNA, miR-34c, miR-183, miR-210, NSCLC, Epidermal growth factor receptor
Journal
Diagnostic Pathology
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-13
DOI
10.1186/s13000-015-0339-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers
- (2014) F. Xu et al. Clinical & Translational Oncology
- microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation
- (2013) Yi Shen et al. MEDICAL ONCOLOGY
- MicroRNAs as potential biomarkers in human solid tumors
- (2012) Jun Shen et al. CANCER LETTERS
- Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
- (2012) J. S. Jang et al. CLINICAL CANCER RESEARCH
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
- (2012) S Catuogno et al. ONCOGENE
- The Association of MicroRNA Expression with Prognosis and Progression in Early-Stage, Non-Small Cell Lung Adenocarcinoma: A Retrospective Analysis of Three Cohorts
- (2011) M. Saito et al. CLINICAL CANCER RESEARCH
- MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas
- (2011) Yingyi Wang et al. JOURNAL OF NEURO-ONCOLOGY
- Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer
- (2011) Françoise Rothé et al. PLoS One
- MicroRNA miR-183 Functions as an Oncogene by Targeting the Transcription Factor EGR1 and Promoting Tumor Cell Migration
- (2010) A. L. Sarver et al. CANCER RESEARCH
- miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity
- (2010) M-P Puisségur et al. CELL DEATH AND DIFFERENTIATION
- miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions
- (2010) Zandra Hagman et al. INTERNATIONAL JOURNAL OF CANCER
- Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer
- (2010) Zhibin Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression
- (2010) Z Chen et al. ONCOGENE
- PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR
- (2009) M. L. Sos et al. CANCER RESEARCH
- Uncovering Growth-Suppressive MicroRNAs in Lung Cancer
- (2009) X. Liu et al. CLINICAL CANCER RESEARCH
- Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation
- (2009) William C.S. Cho et al. EUROPEAN JOURNAL OF CANCER
- Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma
- (2009) Justin A. Bishop et al. HUMAN PATHOLOGY
- Modulation of microRNA processing by p53
- (2009) Hiroshi I. Suzuki et al. NATURE
- EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
- (2008) G. J. Weiss et al. ANNALS OF ONCOLOGY
- Molecular Selection of Patients for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer With Epidermal Growth Factor Inhibitors: Not Quite Ready for Prime Time
- (2008) Frances A. Shepherd JOURNAL OF CLINICAL ONCOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started